The development of pancreatic cancer often occurs through the accumulation of genetic mutations, including frequent mutations in the KRAS (Kirsten rat sarcoma viral oncogene homolog), p53, CDKN2A (p16) and SMAD4 (DPC4) [35]. This evidence concerns the gene CDKN2A and pancreatic neoplasm.